Conestoga Capital Advisors LLC Purchases 50,577 Shares of Mesa Laboratories, Inc. (MLAB)
Conestoga Capital Advisors LLC lifted its position in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 13.6% during the fourth quarter, HoldingsChannel reports. The firm owned 423,804 shares of the medical instruments supplier’s stock after purchasing an additional 50,577 shares during the quarter. Mesa Laboratories comprises about 2.0% of Conestoga Capital Advisors LLC’s holdings, making the stock its 25th largest holding. Conestoga Capital Advisors LLC owned approximately 0.11% of Mesa Laboratories worth $52,679,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Capital Analysts LLC acquired a new position in shares of Mesa Laboratories during the third quarter worth $128,000. SG Americas Securities LLC acquired a new position in shares of Mesa Laboratories during the third quarter worth $131,000. Voya Investment Management LLC acquired a new position in shares of Mesa Laboratories during the second quarter worth $221,000. Westfield Capital Management Co. LP acquired a new position in shares of Mesa Laboratories during the third quarter worth $239,000. Finally, Timber Hill LLC acquired a new position in shares of Mesa Laboratories during the third quarter worth $298,000. 69.95% of the stock is currently owned by institutional investors and hedge funds.
Several equities analysts have recently commented on MLAB shares. Zacks Investment Research lowered shares of Mesa Laboratories from a “buy” rating to a “strong sell” rating in a research report on Friday, November 10th. TheStreet upgraded shares of Mesa Laboratories from a “c+” rating to a “b” rating in a research report on Monday, November 6th.
Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings data on Monday, November 6th. The medical instruments supplier reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.64 by ($0.04). The company had revenue of $22.95 million during the quarter, compared to analyst estimates of $25.50 million. Mesa Laboratories had a return on equity of 14.77% and a net margin of 11.48%. research analysts expect that Mesa Laboratories, Inc. will post 2.47 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Wednesday, February 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.48%. The ex-dividend date is Tuesday, February 27th. Mesa Laboratories’s payout ratio is currently 23.10%.
TRADEMARK VIOLATION WARNING: This report was first published by Watch List News and is owned by of Watch List News. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at https://www.watchlistnews.com/conestoga-capital-advisors-llc-purchases-50577-shares-of-mesa-laboratories-inc-mlab/1818547.html.
About Mesa Laboratories
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Want to see what other hedge funds are holding MLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mesa Laboratories, Inc. (NASDAQ:MLAB).
Receive News & Ratings for Mesa Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.